Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth L Siegler

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Nature Communications|September 12, 2024
IL-4 drives exhaustion of CD8<sup>+</sup> CART cellsCarli M Stewart, Elizabeth L Siegler, R Leo Sakemura, et al.
Leukemia|April 20, 2022
GM-CSF disruption in CART cells modulates T cell activation and enhances CART cell anti-tumor activityMichelle J Cox, Claudia Manriquez Roman, Erin E Tapper, et al.
Molecular Cancer|June 10, 2025
Differential susceptibility and role for senescence in CART cells based on costimulatory domainsIsmail Can, Elizabeth L Siegler, Olivia L Sirpilla, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 3, 2021
Leukemic extracellular vesicles induce chimeric antigen receptor T cell dysfunction in chronic lymphocytic leukemiaMichelle J Cox, Fabrice Lucien, Reona Sakemura, et al.
Blood|January 28, 2022
Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myelomaReona Sakemura, Mehrdad Hefazi, Elizabeth L Siegler, et al.
Nature Biomedical Engineering|April 1, 2024
Mesenchymal stromal cells with chimaeric antigen receptors for enhanced immunosuppressionOlivia Sirpilla, R Leo Sakemura, Mehrdad Hefazi, et al.
Molecular Therapy. Oncology|June 3, 2025
Intrinsic immunosuppressive features of monocytes suppress CAR-T19 through IL-1 pathway modulation in mantle cell lymphomaKun Yun, R Leo Sakemura, Ismail Can, et al.
Cancer Immunology Research|July 10, 2021
Development of a Clinically Relevant Reporter for Chimeric Antigen Receptor T-cell Expansion, Trafficking, and ToxicityReona Sakemura, Aditya Bansal, Elizabeth L Siegler, et al.
Blood|October 25, 2023
CD19 occupancy with tafasitamab increases therapeutic index of CART19 cell therapy and diminishes severity of CRSR Leo Sakemura, Claudia Manriquez Roman, Paulina Horvei, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Optimized CART Cell Therapy for Metastatic Aggressive Thyroid CancerClaudia Manriquez Roman, Elizabeth L Siegler, Justyna J Gleba, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Nature Communications|September 12, 2024
IL-4 drives exhaustion of CD8<sup>+</sup> CART cellsCarli M Stewart, Elizabeth L Siegler, R Leo Sakemura, et al.
Leukemia|April 20, 2022
GM-CSF disruption in CART cells modulates T cell activation and enhances CART cell anti-tumor activityMichelle J Cox, Claudia Manriquez Roman, Erin E Tapper, et al.
Molecular Cancer|June 10, 2025
Differential susceptibility and role for senescence in CART cells based on costimulatory domainsIsmail Can, Elizabeth L Siegler, Olivia L Sirpilla, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 3, 2021
Leukemic extracellular vesicles induce chimeric antigen receptor T cell dysfunction in chronic lymphocytic leukemiaMichelle J Cox, Fabrice Lucien, Reona Sakemura, et al.
Blood|January 28, 2022
Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myelomaReona Sakemura, Mehrdad Hefazi, Elizabeth L Siegler, et al.
Nature Biomedical Engineering|April 1, 2024
Mesenchymal stromal cells with chimaeric antigen receptors for enhanced immunosuppressionOlivia Sirpilla, R Leo Sakemura, Mehrdad Hefazi, et al.
Molecular Therapy. Oncology|June 3, 2025
Intrinsic immunosuppressive features of monocytes suppress CAR-T19 through IL-1 pathway modulation in mantle cell lymphomaKun Yun, R Leo Sakemura, Ismail Can, et al.
Cancer Immunology Research|July 10, 2021
Development of a Clinically Relevant Reporter for Chimeric Antigen Receptor T-cell Expansion, Trafficking, and ToxicityReona Sakemura, Aditya Bansal, Elizabeth L Siegler, et al.
Blood|October 25, 2023
CD19 occupancy with tafasitamab increases therapeutic index of CART19 cell therapy and diminishes severity of CRSR Leo Sakemura, Claudia Manriquez Roman, Paulina Horvei, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Optimized CART Cell Therapy for Metastatic Aggressive Thyroid CancerClaudia Manriquez Roman, Elizabeth L Siegler, Justyna J Gleba, et al.
Pageof 4